Platelet count at baseline (Plt) and outcomes in patients (pts) with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S) in CALGB 80802 (Alliance) (C8) Abou-Alfa, Ghassan K. , Shi, Qian , Knox, Jennifer J. ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80802
A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer: an Alliance Foundation trial (AFT-19) Aggarwal, Rahul , Eggener, Scott , Chen, Ronald , Heller, Glenn ... - ASCO - J Clin Oncol - 2018 Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - GU - AFT-19
Comparative analysis of outcomes in African American (AA) and white (W) patients (pts) with multiple myeloma (MM) treated with lenalidomide (LEN) or pomalidomide (POM) CALGB 100104 (Alliance) Ailawadhi, Sikander , McCarthy, Philip L. , Holstein, Sarah A. ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Meta-Analysis Analysis - Transplant - CALGB-100104 , E4A03 , MM-002 , MM-009
Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-66 Alberts, Steven R. , Roh, Mark S. , Mahoney, Michelle R. ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - GI - N9945
Alliance A031501: Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (MIBC) (AMBASSADOR) vs Observation Apolo, Andrea , Rosenberg, Jonathan , Morris, Michael ... - ASCO GU - J Clin Oncol - 2019 Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - GU - A031501
Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720 Baer, Maria R. , George, Stephen L. , Caligiuri, Michael A. ... - - J Clin Oncol - 2008 Manuscript - Secondary Endpoint - Primary Analysis - Leukemia - CALGB-8461 , CALGB-9720
Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study Becker, Heiko , Marcucci, Guido , Maharry, Kati ... - - J Clin Oncol - 2010 Manuscript - Secondary Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-10201 , CALGB-19808 , CALGB-20202 , CALGB-8461 , CALGB-9720
Randomized phase II trial of pazopanib versus placebo in patients with progressive carcinoid tumors (CARC) (Alliance A021202). Bergsland, Emily K. , Mahoney, Michelle R. , Asmis, Timothy R. ... - ASCO - J Clin Oncol - 2019 Abstract - Primary Endpoint - Primary Analysis - GI - A021202
Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803 Bertagnolli, Monica M. , Niedzwiecki, Donna , Compton, Carolyn C. ... - - J Clin Oncol - 2009 Manuscript - Secondary Endpoint - Primary Analysis - GI - CALGB-150705 , CALGB-89803
Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer—A Study of CALGB 9581 and 89803 Bertagnolli, Monica M. , Redston, Mark , Compton, Carolyn C. ... - - J Clin Oncol - 2011 Manuscript - Primary Endpoint - Primary Analysis - GI - C150705 , C89803 , C9581
Phase I Study of Accelerated Conformal Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Patients With Pulmonary Dysfunction: CALGB 39904 Bogart, Jeffrey A. , Hodgson, Lydia , Seagren, Stephen L. ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-39904
Factors associated with lymphedema in patients/women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection on a prospective clinical trial (Alliance) ACOSOG Z1071 Boughey, Judy C. , Ballman, Karla , McCall, Linda , Kuerer, Henry ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary Endpoint - Primary Analysis - Breast - ACOSOG-Z1071
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177 Brown, Paul D. , Krishnan, Sunil , Sarkaria, Jann N. , Wu, Wenting ... - - J Clin Oncol - 2008 Manuscript - Primary Endpoint - Primary Analysis - Neuro-Onc - N0177
Quality-adjusted time without symptoms or toxicity (Q-TWiST): analysis of cabozantinib versus sunitinib in patients with advanced renal cell carcinoma of intermediate or poor risk (Alliance A031203) Chen, RC , Feuilly, M , Meng, J , Lister, J , Marteau, F , Morris, M ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - A031203
Association between adaptive immune signature and outcome in HER2-positive breast cancer treated with trastuzumab and lapatinib in the NCCTG-N9831 (Alliance) and NeoALTTO trials Chumsri, Saranya , Serie, Daniel , Mashadi-Hossein, Afshin ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - N9831
Correlation of high p95HER2:HER2 ratio with poor outcome in two phase II clinical trials of trastuzumab-treated HER2-positive metastatic breast cancer. Chumsri, Saranya , Sperinde, Jeff , Liu, Heshan , Gligorov, Joseph ... - ASCO - J Clin Oncol - 2016 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Breast - N0337 , N98-32-52
Sentinel Lymph Node Biopsy Accurately Stages the Regional Lymph Nodes for T1-T2 Oral Squamous Cell Carcinomas: Results of a Prospective Multi-Institutional Trial Civantos, Francisco J. , Zitsch, Robert P. , Schuller, David E. ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - GI - ACOSOG-Z0360
Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909 Damon, Lloyd E. , Johnson, Jeffrey L. , Niedzwiecki, Donna ... - - J Clin Oncol - 2009 Manuscript - Primary Endpoint - Primary Analysis - Lymphoma - CALGB-59909
Is there a role for older-patient-specific trials? a pooled analysis of 2277 older patients in adjuvant breast cancer trials (Alliance A151715) Dao, Dyda , Zelma, Tyler , Jatoi, Aminah , Freedman, Rachel ... - ASCO - J Clin Oncol - 2018 Abstract - Primary Endpoint - Primary Analysis - Older Adult - A151715 , C8541 , CALGB-40101 , CALGB-49907 , CALGB-9344 , CALGB-9741 , N89-30-52 , N9831
Loss of p27 expression and response to neoadjuvant chemotherapy: Results from the I-SPY Trial (CALGB150007/150012, ACRIN6657) Demichele, A. , Dunn, L. , Gimotty, P. , Livasy, C. , Perou, C. ... - ASCO - J Clin Oncol - 2009 Abstract - Secondary Endpoint - Primary Analysis - Correl Sci NOS - CALGB-150007
Randomized phase 2 study of maintenance pemetrexed versus observation for patients (pts) with malignant pleural mesothelioma (MPM) without progression after first-line chemotherapy: Cancer and Leukemia Group B (CALGB/Alliance) 30901 Dudek, Arkadiusz Z. , Wang, Xiaofei , Gu, Lin , Stinchcombe, Thomas ... - ASCO - J Clin Oncol - 2019 Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30901
Causal modeling of CALGB 80405 (Alliance) identifies network drivers of metastatic colorectal cancer (CRC) Federico Innocenti , Heinz-Josef Lenz , Jeffrey Meyerhardt ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80405
ECOG score analysis as a proxy for health-related quality of life assessment in patients with poor or intermediate risk metastatic renal cell carcinoma from the CABOSUN trial (Alliance A031203) Feldman, D , Feuilly, M , Meng, J , Lister, J , Marteau, F , Morris, MJ ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - A031203
Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841 Franko, Jan , Shi, Qian , Goldman, Charles D. , Pockaj, Barbara A. ... - - J Clin Oncol - 2012 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - N9841 , N9741
Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study Galanis, Evanthia , Jaeckle, Kurt A. , Maurer, Matthew J. ... - - J Clin Oncol - 2009 Manuscript - Primary Endpoint - Primary Analysis - Neuro-Onc - N047B
Cabozantinib versus sunitinib for previously untreated patients with advanced renal cell carcinoma (RCC) of intermediate or poor risk: subgroup analysis of progression-free survival (PFS) and objective response rate (ORR) in the Alliance A031203 CABOSUN trial George, Daniel , Hessel, Colin , Halabi, Susan , Sanford, Ben ... - ASCO GU - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GU - A031203
Variability of Pelvic MRI Performance in a Prospective Multicenter Rectal Cancer Trial NCCTG N1048 (Alliance) Gollub, Marc J. , Shi, Qian , Nougaret, Stephanie ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - N1048
Phase III, randomized, double blind, placebo (P)-controlled trial of sorafenib (S) in desmoid tumor, (DT) (ALLIANCE A091105) Gounder, Mrinal M. , Mahoney, Michelle R. , Van Tine, Brian Andrew ... - ASCO - J Clin Oncol - 2018 Abstract - Primary Endpoint - Primary Analysis - Experimental - A091105
Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407 Govindan, Ramaswamy , Bogart, Jeffrey , Stinchcombe, Thomas ... - - J Clin Oncol - 2011 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30407
Menstrual Cycle and Surgical Treatment of Breast Cancer: Findings From the NCCTG N9431 Study Grant, Clive S. , Ingle, James N. , Suman, Vera J. ... - - J Clin Oncol - 2009 Manuscript - Primary Endpoint - Primary Analysis - Breast - N9431
Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7 Grothey, Axel , Nikcevich, Daniel A. , Sloan, Jeff A. ... - - J Clin Oncol - 2011 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N04C7
Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer Halabi, Susan , Vogelzang, Nicholas J. , Ou, San-San , Owzar, Kouros ... - - J Clin Oncol - 2009 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GU - Comprehensive
Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831 Halyard, Michele Y. , Pisansky, Thomas M. , Dueck, Amylou C. ... - - J Clin Oncol - 2009 Manuscript - Secondary Endpoint - Primary Analysis - Breast - N9831
Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group Heinrich, Michael C. , Owzar, Kouros , Corless, Christopher L. ... - - J Clin Oncol - 2008 Manuscript - Secondary Endpoint - Primary Analysis - PPP - CALGB-150105
Patient Education Level As a Predictor of Survival In Lung Cancer Clinical Trials Herndon, James E. , Kornblith, Alice B. , Holland, Jimmie C. ... - - J Clin Oncol - 2008 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Health Outcome - C8931 , CALGB-8831 , C9130 , CALGB-9033 , C9532 , CALGB-9235 , CALGB-9430 , CALGB-9431 , CALGB-9534 , CALGB-9730 , CALGB-9731
Evaluation of the Optimal Number of Lesions Needed for Tumor Evaluation Using the Response Evaluation Criteria in Solid Tumors: A North Central Cancer Treatment Group Investigation Hillman, Shauna L. , Ming-Wen, An , O'Connell, Michael J. ... - - J Clin Oncol - 2009 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - N9741
Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401 Hurria, Arti , Cirrincione, Constance T. , Muss, Hyman B. ... - - J Clin Oncol - 2011 Manuscript - Primary Endpoint - Primary Analysis - GU - CALGB-360401 , CALGB-99809
A phase I/II trial adding the poly(ADP-ribose) polymerase (PARP) inhibitor veliparib to induction carboplatin-paclitaxel in patients with locoregionally advanced squamous cell carcinoma of the head and neck (HNSCC) Alliance A091101 Jelinek, Michael J. , Foster, Nathan R. , Zoroufy, Alex J. ... - ASCO - J Clin Oncol - 2018 Abstract - Primary Endpoint - Preliminary Analysis - Experimental - A091101
Phase III Noninferiority Trial Comparing Irinotecan With Oxaliplatin, Fluorouracil, and Leucovorin in Patients With Advanced Colorectal Carcinoma Previously Treated With Fluorouracil: N9841 Kim, George P. , Sargent, Daniel J. , Mahoney, Michelle R. ... - - J Clin Oncol - 2009 Manuscript - Primary Endpoint - Primary Analysis - GI - N9841
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) Kindler, Hedy Lee , Niedzwiecki, Donna , Hollis, Donna ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - GI - CALGB-80303
Quality of Life of Older Patients With Early-Stage Breast Cancer Receiving Adjuvant Chemotherapy: A Companion Study to Cancer and Leukemia Group B 49907 Kornblith, Alice B. , Lan, Lan , Archer, Laura , Partridge, Ann ... - - J Clin Oncol - 2011 Manuscript - Secondary Endpoint - Primary Analysis - Health Outcome - CALGB-70103 , CALGB-49907
Increasing Adherence to Adjuvant Hormone Therapy among Breast Cancer Patients: A Smart Phone App-Based Pilot Study Krok-Schoen, Jessica L. , Naughton, Michelle J. , Young, Gregory S. ... - ASCO - J Clin Oncol - 2018 Abstract - Primary Endpoint - Primary Analysis - Health Outcome - Pilot
Randomized Phase II Study of Gemcitabine Administered at a Fixed Dose Rate or in Combination With Cisplatin, Docetaxel, or Irinotecan in Patients With Metastatic Pancreatic Cancer: CALGB 89904 Kulke, Matthew H. , Tempero, Margaret A. , Niedzwiecki, Donna ... - - J Clin Oncol - 2009 Manuscript - Primary Endpoint - Primary Analysis - GI - CALGB-89904
Differences in Clinical Trial Patient Attributes and Outcomes According to Enrollment Setting Lamont, Elizabeth B. , Landrum, Mary Beth , Keating, Nancy L. ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Disparities - CALGB-70602
Prognostic Importance of MN1 Transcript Levels, and Biologic Insights From MN1-Associated Gene and MicroRNA Expression Signatures in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study Langer, Christian , Marcucci, Guido , Holland, Kelsi B. ... - - J Clin Oncol - 2009 Manuscript - Secondary Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-19808 , CALGB-20502 , CALGB-8461 , CALGB-9621 , CALGB-9665
The Breast Cancer Weight Loss (BWEL) Trial: Randomized Phase III Trial Evaluating The Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer (Alliance A011401) Ligibel, Jennifer A. , Barry, William T. , Alfano, Catherine ... - ASCO - J Clin Oncol - 2018 Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Breast - A011401
Randomized Phase II Trial of Docetaxel Plus Cetuximab or Docetaxel Plus Bortezomib in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2: CALGB 30402 Lilenbaum, Rogerio , Wang, Xiaofei , Gu, Lin , Kirshner, Jeffrey ... - - J Clin Oncol - 2009 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30402
Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101 Lin, Thomas S. , Donohue, Kathleen A. , Byrd, John C. ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Leukemia - CALGB-10101
Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes, N07C1 Loprinzi, Charles L. , Qin, Rui , Baclueva, Ernie P. ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N07C1
A randomized phase ii study of anti-PD-1 antibody [MK-3475 (pembrolizumab)] alone versus anti-PD1 antibody plus stereotactic body radiation therapy in advanced merkel cell carcinoma (Alliance A091605) Luke, Jason , Chmura, Steven , Salama, Joseph , Al-Hallaq, Hania ... - ASCO - J Clin Oncol - 2018 Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Experimental - A091605
Breast Cancer Adjuvant Chemotherapy Decisions in Older Women: The Role of Patient Preference and Interactions With Physicians Mandelblatt, Jeanne S. , Sheppard, Vanessa B. , Hurria, Arti ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - CALGB-369901
Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study Marcucci, Guido , Maharry, Kati , Radmacher, Michael D. ... - - J Clin Oncol - 2008 Manuscript - Secondary Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-19808 , CALGB-20502 , CALGB-8461 , CALGB-9621 , CALGB-9665
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study Marcucci, Guido , Maharry, Kati , Wu, Yue-Zhong ... - - J Clin Oncol - 2010 Manuscript - Secondary Endpoint - Primary Analysis - Leuk Corr Sci - C8421 , C8525 , CALGB-10201 , CALGB-19808 , CALGB-20202 , CALGB-20502 , CALGB-8923 , CALGB-9420 , CALGB-9621 , CALGB-9665 , CALGB-9720
Phase III, Double-Blind Study of Depot Octreotide Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy: Results of North Central Cancer Treatment Group N00CA Martenson, James A. , Halyard, Michele Y. , Sloan, Jeff A. ... - - J Clin Oncol - 2008 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N00CA
Elevated Serum Free Light Chains Are Associated With Event-Free and Overall Survival in Two Independent Cohorts of Patients With Diffuse Large B-Cell Lymphoma Maurer, Matthew J. , Micallef, Ivana N.M. , Cerhan, James R. ... - - J Clin Oncol - 2011 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Lymphoma - N0489
Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741 McLeod, Howard L. , Sargent, Daniel J. , Marsh, Sharon ... - - J Clin Oncol - 2010 Manuscript - Secondary Endpoint - Primary Analysis - PPP - N9741
TET2 Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study Metzeler, Klaus H. , Maharry, Kati , Radmacher, Michael D. ... - - J Clin Oncol - 2011 Manuscript - Secondary Endpoint - Primary Analysis - Leuk Corr Sci - C8525 , CALGB-10201 , CALGB-19808 , CALGB-20202 , CALGB-20502 , CALGB-8461 , CALGB-8923 , CALGB-9420 , CALGB-9621 , CALGB-9665 , CALGB-9720
Impact of Body Mass Index and Weight Change After Treatment on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From Cancer and Leukemia Group B 89803 Meyerhardt, Jeffrey A. , Niedzwiecki, Donna , Hollis, Donna ... - - J Clin Oncol - 2008 Manuscript - Secondary Endpoint - Primary Analysis - GI - C89803
Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336 Moreno-Aspitia, Alvaro , Morton, Roscoe F. , Hillman, David W. ... - - J Clin Oncol - 2009 Manuscript - Primary Endpoint - Primary Analysis - Breast - N0336
Patients With Acute Myeloid Leukemia and RAS Mutations Benefit Most From Postremission High-Dose Cytarabine: A Cancer and Leukemia Group B Study Neubauer, Andreas , Maharry, Kati , Mrózek, Krzysztof ... - - J Clin Oncol - 2008 Manuscript - Secondary Endpoint - Primary Analysis - Leuk Corr Sci - C8525 , C8765 , CALGB-8461 , CALGB-9665
Multivitamin Use Is Not Associated With Cancer Recurrence or Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 Ng, Kimmie , Meyerhardt, Jeffrey A. , Chan, Jennifer A. ... - - J Clin Oncol - 2010 Manuscript - Secondary Endpoint - Primary Analysis - GI - CALGB-8461 , CALGB-9665
Vitamin D Status in Patients With Stage IV Colorectal Cancer: Findings From Intergroup Trial N9741 Ng, Kimmie , Sargent, Daniel J. , Goldberg, Richard M. ... - - J Clin Oncol - 2011 Manuscript - Secondary Endpoint - Primary Analysis - Correl Sci NOS - N9741
Documenting the Natural History of Patients With Resected Stage II Adenocarcinoma of the Colon After Random Assignment to Adjuvant Treatment With Edrecolomab or Observation: Results From CALGB 9581 Niedzwiecki, Donna , Bertagnolli, Monica M. , Warren, Robert S. ... - - J Clin Oncol - 2011 Manuscript - Primary Endpoint - Primary Analysis - GI - C9581
Lessons learned from implementing the first Alliance NCORP Research Base Cancer Care Delivery Research (CCDR) trial A191402CD Pacyna, Joel E. , Sloan, Jeff , Kim, Simon , Sedlacek, Hillary ... - ASCO QCS - J Clin Oncol - 2018 Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Disparities - A191402CD
Adherence and Persistence With Oral Adjuvant Chemotherapy in Older Women With Early-Stage Breast Cancer in CALGB 49907: Adherence Companion Study 60104 Partridge, Ann H. , Archer, Laura , Kornblith, Alice B. ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Experimental - CALGB-60104 , CALGB-49907
Wilms’ Tumor 1 Gene Mutations Independently Predict Poor Outcome in Adults With Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study Paschka, Peter , Marcucci, Guido , Ruppert, Amy S. ... - - J Clin Oncol - 2008 Manuscript - Secondary Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-19808 , CALGB-20502 , CALGB-8461 , CALGB-9621 , CALGB-9665
Genome-wide association with survival in stage II-III colon cancer (CC) clinical trials (NCCTG N0147, Alliance for Clinical Trials in Oncology; NSABP C-08, NRG Oncology) Penney, Kathryn , Banbury, Barbara L. , Shi, Qian ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - PPP - N0147
C-MYC Alterations and Association With Patient Outcome in Early-Stage HER2-Positive Breast Cancer From the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial Perez, Edith A. , Jenkins, Robert B. , Dueck, Amylou C. ... - - J Clin Oncol - 2011 Manuscript - Secondary Endpoint - Primary Analysis - Breast - N9831
HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial Perez, Edith A. , Reinholz, Monica M. , Hillman, David W. ... - - J Clin Oncol - 2010 Manuscript - Secondary Endpoint - Primary Analysis - Breast - N9831
Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31 Perez, Edith A. , Romond, Edward H. , Suman, Vera J. ... - - J Clin Oncol - 2011 Manuscript - Primary Endpoint - Long-Term-Followup Analysis - Breast - N9831
Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer Perez, Edith A. , Suman, Vera J. , Davidson, Nancy E. ... - - J Clin Oncol - 2011 Manuscript - Primary Endpoint - Primary Analysis - Breast - N9831
Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study Ready, Neal E. , Dudek, Arkadiusz Z. , Pang, Herbert H. ... - - J Clin Oncol - 2011 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30306
Cancer and Leukemia Group B Pathology Committee Guidelines for Tissue Microarray Construction Representing Multicenter Prospective Clinical Trial Tissues Rimm, David L. , Nielsen, Torsten O. , Jewell, Scott D. ... - - J Clin Oncol - 2011 Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Pathology - C9741 , CALGB-9840
Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206 Rini, Brian I. , Halabi, Susan , Rosenberg, Jonathan E. ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - GU - CALGB-90206
Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206 Rini, Brian I. , Halabi, Susan , Rosenberg, Jonathan E. ... - - J Clin Oncol - 2008 Manuscript - Primary Endpoint - Preliminary Analysis - GU - CALGB-90206
Questionable value of attribution when interpreting adverse event data: A joint evaluation by North Central Cancer Treatment Group (NCCTG) and American College of Surgeons Oncology Group (ACOSOG). SL, Hillman , DJ, Sargent , BM, Bot , RP, DeMatteo , EA, Perez ... - ASCO - J Clin Oncol - 2007 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - ACOSOG-Z9001
Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741 Sanoff, Hanna K. , Sargent, Daniel J. , Campbell, Megan E. ... - - J Clin Oncol - 2008 Manuscript - Primary Endpoint - Long-Term-Followup Analysis - GI - N9741
Racial Differences in Advanced Colorectal Cancer Outcomes and Pharmacogenetics: A Subgroup Analysis of a Large Randomized Clinical Trial Sanoff, Hanna K. , Sargent, Daniel J. , Green, Erin M. ... - - J Clin Oncol - 2009 Manuscript - Secondary Endpoint - Primary Analysis - GI - N9741
Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer Sargent, Daniel J. , Köhne, Claus Henning , Sanoff, Hanna Kelly ... - - J Clin Oncol - 2009 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - N9741
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer Sargent, Daniel J. , Marsoni, Silvia , Monges, Genevieve ... - - J Clin Oncol - 2010 Manuscript - Secondary Endpoint - Primary Analysis - GI - N994C
Prognostic Significance of Expression of a Single MicroRNA, miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study Schwind, Sebastian , Maharry, Kati , Radmacher, Michael D. ... - - J Clin Oncol - 2010 Manuscript - Secondary Endpoint - Primary Analysis - Leuk Corr Sci - CALGB-19808 , CALGB-20202 , CALGB-20502 , CALGB-8461 , CALGB-9621 , CALGB-9665
Effect of age, gender, and performance status (PS) on the duration results of adjuvant chemotherapy for stage III colon cancer: the IDEA collaboration Shields, Anthony F. , Ou, Fang-Shu , Paul, James ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - GI - CALGB-80702
Association of Obesity With DNA Mismatch Repair Status and Clinical Outcome in Patients With Stage II or III Colon Carcinoma Participating in NCCTG and NSABP Adjuvant Chemotherapy Trials Sinicrope, Frank A. , Foster, Nathan R. , Yoon, Harry H. ... - - J Clin Oncol - 2012 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - N994C
Immunoscore provides prognostic information in low (T1-3N1) and high risk (T4 or N2) subsets of stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance) Sinicrope, Frank A. , Shi, Qian , Hermitte, Fabienne ... - ASCO GI - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - N0147
Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups Strauss, Gary M. , Herndon, James E. , Maddaus, Michael A. ... - - J Clin Oncol - 2008 Manuscript - Primary Endpoint - Long-Term-Followup Analysis - Respiratory - CALGB-9633
Prognostic value of BRAF V600E and KRAS exon 2 mutations in microsatellite stable (MSS), stage III colon cancers (CC) from patients (pts) treated with adjuvant FOLFOX+/- cetuximab: A pooled analysis of 3934 pts from the PETACC8 and N0147 trials Taieb, Julien , Malicot, Karine Le ... - ASCO - J Clin Oncol - 2015 Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - N0147
Postoperative Surveillance Recommendations for Early Stage Colon Cancer Based on Results From the Clinical Outcomes of Surgical Therapy Trial Tsikitis, Vassiliki L. , Malireddy, Kishore , Green, Erin A. ... - - J Clin Oncol - 2009 Manuscript - Primary Endpoint - Primary Analysis - GI - CALGB-9396
Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5 Wolf, Sherry L. , Qin, Rui , Menon, Smitha P. , Rowland, Kendrith M. ... - - J Clin Oncol - 2010 Manuscript - Primary Endpoint - Primary Analysis - Symptom Inter - N05C5
Objective Measures of Performance Status in Cancer: A pilot Alliance study Wood, WA , Tan, X , Grover, NS , Stover, A , Kannappan, A ... - ASCO QCS - J Clin Oncol - 2018 Abstract - No-Endpoint Endpoint - Primary Analysis - Disparities - Pilot
Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712 Woyach, Jennifer A. , Ruppert, Amy S. , Heerema, Nyla A. ... - - J Clin Oncol - 2011 Manuscript - Primary Endpoint - Long-Term-Followup Analysis - Leukemia - CALGB-9712
CD3+ and CD8+ tumor-infiltrating lymphocyte (TIL) densities prognostically stratify DNA mismatch repair-deficient (dMMR) colon cancer patients (pts): NCCTG N0147 (Alliance) Yoon, Harry H. , Shi, Qian , Heying, Erica N. , Muranyi, Andrea ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Correl Sci NOS - N0147
Association Between Disease-Free Survival and Overall Survival When Survival Is Prolonged After Recurrence in Patients Receiving Cytotoxic Adjuvant Therapy for Colon Cancer: Simulations Based on the 20,800 Patient ACCENT Data Set de Gramont, Aimery , Hubbard, Joleen , Shi, Qian ... - - J Clin Oncol - 2010 Manuscript - Secondary Endpoint - Primary Analysis - GI - N9741
